Results 271 to 280 of about 912,101 (303)
Some of the next articles are maybe not open access.
Nursing Clinics of North America, 2004
Hepatitis C virus is a common blood-borne pathogen that is now declining as a new infection in the population. However, women and men who were infected 2 to 3 decades ago are now developing liver damage. To prevent further damage, treatment with IFN and ribavirin is available.
Monica, Jarrett, Paula, Cox
openaire +2 more sources
Hepatitis C virus is a common blood-borne pathogen that is now declining as a new infection in the population. However, women and men who were infected 2 to 3 decades ago are now developing liver damage. To prevent further damage, treatment with IFN and ribavirin is available.
Monica, Jarrett, Paula, Cox
openaire +2 more sources
Current Treatment Options in Gastroenterology, 2001
Infection with hepatitis C virus (HCV) accounts for 40% of cases of chronic liver disease in the United States and is now the most common indication for liver transplantation. Estimates suggest that 4 million people (1.8%) of the American population are or have been infected with HCV.
Tram T., Tran, Paul, Martin
openaire +2 more sources
Infection with hepatitis C virus (HCV) accounts for 40% of cases of chronic liver disease in the United States and is now the most common indication for liver transplantation. Estimates suggest that 4 million people (1.8%) of the American population are or have been infected with HCV.
Tram T., Tran, Paul, Martin
openaire +2 more sources
Clinics in Liver Disease, 2002
Hepatitis B and C are worldwide infectious hepatitides which are distinct in terms of epidemiology and molecular biology, but which may be quite similar in terms of clinical manifestations and histopathology, in both the acute and chronic stages. Hepatitis B virus (HBV), the human prototype of the Hepadnaviridae family of viruses is not directly ...
openaire +2 more sources
Hepatitis B and C are worldwide infectious hepatitides which are distinct in terms of epidemiology and molecular biology, but which may be quite similar in terms of clinical manifestations and histopathology, in both the acute and chronic stages. Hepatitis B virus (HBV), the human prototype of the Hepadnaviridae family of viruses is not directly ...
openaire +2 more sources
Gastroenterology Nursing, 2008
The purpose of this study was to examine hepatitis C-related stigma within a population of liver disease support group attendees. In total, 39 participants completed a quantitative/qualitative survey during support group meetings. This article reports on the quantitative data.
Grace A, Moore +2 more
openaire +2 more sources
The purpose of this study was to examine hepatitis C-related stigma within a population of liver disease support group attendees. In total, 39 participants completed a quantitative/qualitative survey during support group meetings. This article reports on the quantitative data.
Grace A, Moore +2 more
openaire +2 more sources
Annals of Internal Medicine, 2016
This issue provides a clinical overview of hepatitis C virus, focusing on transmission, prevention, screening, diagnosis, evaluation, and treatment. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program ...
openaire +2 more sources
This issue provides a clinical overview of hepatitis C virus, focusing on transmission, prevention, screening, diagnosis, evaluation, and treatment. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program ...
openaire +2 more sources
Southern Medical Journal, 1997
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +2 more sources
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +2 more sources
2000
Hepatitis C virus infection occurs in all parts of the world. Infection is generally due to percutaneous exposures, though sexual and perinatal transmission may occur. While further study is needed to elucidate the biology of HCV transmission and develop vaccines for prevention, new HCV infections can be reduced by economic development and education ...
openaire +2 more sources
Hepatitis C virus infection occurs in all parts of the world. Infection is generally due to percutaneous exposures, though sexual and perinatal transmission may occur. While further study is needed to elucidate the biology of HCV transmission and develop vaccines for prevention, new HCV infections can be reduced by economic development and education ...
openaire +2 more sources
Cell entry and release of quasi-enveloped human hepatitis viruses
Nature Reviews Microbiology, 2023Anshuman Das +2 more
exaly
The oncologic burden of hepatitis C virus infection: A clinical perspective
Ca-A Cancer Journal for Clinicians, 2017Harrys A Torres +2 more
exaly